Release Date: 26/02/09 14:09 Summary: Net Tangible Asset Backing Price Sensitive: No Download Document 25.28KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%